Department of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Department of Otorhinolaryngology and Head and Neck Surgery, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Biomed Res Int. 2020 Oct 6;2020:3962146. doi: 10.1155/2020/3962146. eCollection 2020.
Tubulin polymerization promoting protein family member 3 (TPPP3) is a kind of protein that can mediate the dynamics and stability of microtubules. However, the correlations of TPPP3 between prognosis and immune infiltrates in different tumors are still unclear. The analysis of TPPP3 expression was performed via Oncomine and Gene Expression Profiling Interactive Analysis (GEPIA) website. We also used GEPIA to assess the impact of TPPPT3 on clinical outcomes. The related pathways involved in TPPP3 were analyzed by gene-set enrichment analysis (GSEA), and the correlation between TPPP3 and immune infiltration was studied by Tumor Immune Estimation Resource2.0 (TIMER 2.0). The TPPP3 expression was significantly reduced in head and neck squamous carcinoma (HNSC) compared to adjacent tissues. In addition, the low expression of TPPP3 in HNSC was significantly associated with prognosis. The pathways closely related to the low expression of TPPP3 are "Antigen Processing and Presentation," "Primary Immunodeficiency," and so on. The TPPP3 expression was negatively correlated with the level of CD8+ T cell, B cell, and myeloid dendritic cell infiltration in HNSC. The TPPP3 expression is closely related to multiple immunomarkers in CD8+ T cell and Myeloid dendritic cells. These data indicate that TPPP3 is associated with multiple cancers and involves multiple immune-related pathways, and TPPP3 is associated with immune infiltration levels. Besides, the TPPP3 expression may help regulate tumor-associated CD8 + T cells, DC cells in HNSC. We conclude TPPP3 can be considered as a biomarker for predicting head and neck squamous cell carcinoma prognosis and immune infiltration.
微管蛋白聚合促进蛋白家族成员 3(TPPP3)是一种可以调节微管动态和稳定性的蛋白质。然而,TPPP3 在不同肿瘤中的预后与免疫浸润之间的相关性尚不清楚。通过 Oncomine 和基因表达谱分析交互分析(GEPIA)网站分析 TPPP3 的表达。我们还使用 GEPIA 评估 TPPPT3 对临床结局的影响。通过基因集富集分析(GSEA)分析与 TPPP3 相关的途径,并通过肿瘤免疫估计资源 2.0(TIMER 2.0)研究 TPPP3 与免疫浸润的相关性。与邻近组织相比,头颈部鳞状细胞癌(HNSC)中 TPPP3 的表达明显降低。此外,HNSC 中 TPPP3 的低表达与预后显著相关。与 TPPP3 低表达密切相关的途径是“抗原加工和呈递”、“原发性免疫缺陷”等。TPPP3 的表达与 HNSC 中 CD8+T 细胞、B 细胞和髓样树突状细胞浸润水平呈负相关。TPPP3 的表达与 CD8+T 细胞和髓样树突状细胞中的多个免疫标志物密切相关。这些数据表明,TPPP3 与多种癌症相关,涉及多种免疫相关途径,与免疫浸润水平相关。此外,TPPP3 的表达可能有助于调节 HNSC 中的肿瘤相关 CD8+T 细胞、DC 细胞。我们得出结论,TPPP3 可作为预测头颈部鳞状细胞癌预后和免疫浸润的标志物。